What to look for beyond "pathogenic" factors in senile dementia? A functional deficiency of Ca2+ signaling

Journal of Alzheimer's Disease

Volumn 27, Issue 4, 2011, Pages 679-689

  Chen, Ming ^a,b   Nguyen, Huey T ^a   Sawmiller, Darrell R ^a  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

Alzheimer's disease; amyloid; calcium; review

Indexed keywords

AMPA RECEPTOR AGONIST; CAFFEINE; CALBINDIN; CALCINEURIN; CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE; CALCIUM CHANNEL BLOCKING AGENT; CALCIUM ION; CALPAIN; FREE RADICAL; MUSCARINIC AGENT; NICOTINE; NICOTINIC AGENT; PRESENILIN;

AGING; ALZHEIMER DISEASE; ARTICLE; CALCIUM ABSORPTION; CALCIUM SIGNALING; CELL DEATH; COGNITION; CYTOSOL; DIABETES MELLITUS; DNA FRAGMENTATION; DOWN REGULATION; ENERGY METABOLISM; GALLSTONE; GENE EXPRESSION; GENE MUTATION; HUMAN; HYPERTENSION; NEPHROLITHIASIS; NERVE CELL; NEUROPROTECTION; NEUROTRANSMISSION; NONHUMAN; OSSIFICATION; OSTEOLYSIS; PRIORITY JOURNAL; SENILE DEMENTIA; STROKE;

EID: 84455193328     PISSN: 13872877     EISSN: 18758908     Source Type: Journal    
DOI: 10.3233/JAD-2011-111142     Document Type: Article

References (65)

1. Selkoe DJ (2001) Alzheimers disease: Genes, proteins, and therapy. Physiol Rev 81, 741-766
2. Khachaturian ZS (2000) Toward a comprehensive theory of Alzheimers disease-challenges, caveats, and parameters. Ann N Y Acad Sci 924, 184-193 (Pubitemid 32050200)
3. Chen M, Maleski JJ, Sawmiller DR (2011) Scientific truth or false hope? Understanding Alzheimers disease from an aging perspective. J Alzheimers Dis 24, 3-10
4. Chen M, Fernandez HL (2001) Alzheimers disease revisited years later: Is it a "disease" or senile condition? Front. Biosci 6, e30-e40
5. Whitehouse PJ, George DR, and DAlton S (2011) Describing the dying days of "Alzheimers Disease". J Alzheimers Dis 24, 11-13
6. Moalem S, Percy ME (2002) The quandary of reductionism: Relevance to Alzheimer disease research. J Alzheimers Dis 4, 531-537 (Pubitemid 36142843)
7. Castellani RJ, Zhu X, Lee HG, Smith MA, Perry G (2009) Molecular pathogenesis of Alzheimers disease: Reductionist versus expansionist approaches. Int J Mol Sci 10, 1386-1406
8. Swerdlow RH (2007) Is aging part of Alzheimers disease, or is Alzheimers disease part of aging? Neurobiol Aging 28, 1465-1480
9. Bishop NA, Lu T, Yankner BA (2010) Neural mechanisms of ageing and cognitive decline. Nature 464, 529-535
10. Brunden KR, Trojanowski JQ, Lee VM (2009) Advances in tau-focused drug discovery for Alzheimers disease and related tauopathies. Nat Rev Drug Discov 8, 783-793
11. Khachaturian ZS (1994) Calcium hypothesis of Alzheimers disease and brain ageing. Ann NY Acad Sci 747, 1-11
12. Aguzzi A, Haass C (2003) Games played by rogue proteins in prion disorders and Alzheimers disease. Science 302, 814-818 (Pubitemid 37339613)
13. Katz B, Miledi R (1967) The timing of calcium action during neuromuscular transmission. J Physiol 189, 535-544
14. Llińas RR (1982) Calcium in synaptic transmission. Sci Am 247, 56-65 (Pubitemid 13249029)
15. Miller RJ (1988) Calcium signalling in neurons. Trends Neurosci 11, 415-419
16. Lynch G, Baudry M (1984) The biochemistry of memory: A new and specific hypothesis. Science 224, 1057-1063 (Pubitemid 14106380)
17. Kandel ER, Schwartz JH (1991) Principles of Neural Science, 3rd edn. Simon & Schuester, New York
18. Gunter TE, Pfeiffer DR (1990) Mechanisms by which mitochondria transport calcium. Am J Physiol 258(5 Pt 1), C755-C786 (Pubitemid 20179411)
19. 2+ signal lower in the disease? Front Biosci 4, a9-a15
20. Berridge MJ, Bootman MD, Lipp P (1998) Calcium - a life and death signal. Nature 395, 645-648 (Pubitemid 28475949)
21. ChenM(1998) The Alzheimers plaques, tangles and memory deficits may have a common origin-Part I: A calcium deficit hypothesis. Front Biosci 3, a27-a31
22. 2+ so difficult to measure? Cell Calcium 26, 149-153
23. Chen M, Fernandez HL (2001) Where do plaques and tangles of Alzheimers disease come from? Aging-related protein degradation inefficiency. Front Biosci 6, e1-e11
24. Whitehouse P, George D (2008) The myth of Alzheimers: What you arent being told about todays most dreaded diagnosis, St. Martins Press, New York
25. Fratiglioni L, Qiu C (2009) Prevention of common neurodegenerative disorders in the elderly. Exp Gerontol 44, 46-50
26. RollandY, Abellan van Kan G,VellasB(2008) Physical activity and Alzheimers disease: From prevention to therapeutic perspectives. J Am Med Dir Assoc 9, 390-405
27. Berridge MJ, Galione A (1988) Cytosolic calcium oscillators. FASEB J 2, 3074-3082
28. Putney Jr. JW (1998) Calcium signaling: Up, down, up, down⋯whats the point? Science 279, 191-192
29. 2+signaling in neurons. Cell Calcium 24, 359-366
30. Eskelinen MH, Kivipelto M (2010) Caffeine as a protective factor in dementia and Alzheimers disease. J Alzheimers Dis 20, S167-S174
31. Gray R, Rajan AS, Radcliffe KA,Yakehiro M, Dani JA(1996) Hippocampal synaptic transmission enhanced by lowconcentrations of nicotine. Nature 383, 713-716 (Pubitemid 26360646)
32. Friel DD (1995) Calcium oscillations in neurons. Ciba Found Symp 188, 210-223
33. Haass M, Kübler W (1997) Nicotine and sympathetic neurotransmission. Cardiovasc Drugs Ther 10, 657-665
34. Fisher A (2008) Cholinergic treatments with emphasis on m1 muscarinic agonists as potential disease-modifying agents for Alzheimers disease. Neurotherapeutics 5, 433-442 (Pubitemid 351952486)
35. 2+ states in Alzheimers disease need to be revisited? J Neuropathol Exp Neurol 58, 310-311
36. Jourdi H, Yanagihara T, Martinez U, Bi X, Lynch G, Baudry M (2005) Effects of positive AMPA receptor modulators on calpain-mediated spectrin degradation in cultured hippocampal slices. Neurochem Int 46, 31-40 (Pubitemid 39572784)
37. Lynch G (1998) Memory and the brain: Unexpected chemistries and a new pharmacology. Neurobiol Learn Mem 70, 82-100 (Pubitemid 28455584)
38. Fratiglioni L, Wang HX, Ericsson K, Maytan M, Winblad B (2000) Influence of social network on occurrence of dementia: A community-based longitudinal study. Lancet 355, 1315-1319 (Pubitemid 30199003)
39. Whitehouse P, George D (2008) The myth of Alzheimers: What you arent being told about todays most dreaded diagnosis, St. Martins Press, New York
40. Chen M, Fernandez HL (2000) Revisiting Alzheimers disease from a new perspective: Can "risk factors" play a key role? J Alzheimers Dis 2, 97-108
41. Khachaturian ZS (1985) Diagnosis of Alzheimers disease. Arch Neurol 42, 1097-1105
42. Maxwell CJ, Hogan DB, Ebly EM (1999) Calcium-channel blockers and cognitive function in elderly people: Results from the Canadian study of health and aging. CMAJ 161, 501-506 (Pubitemid 29433523)
43. Heckbert SR, longstrethWTJr, Psaty BM, Murros KE, Smith NL, Newman AB, Williamson JD, Bernick C, Furberg CD (1997) The association of antihypertensive agents with MRI white matter findings and with modified mini-mental state examination in older adults. J Am Geriatr Soc 45, 1423-1433 (Pubitemid 127747111)
44. Christ G, Wingard C (2005) Calcium sensitization as a pharmacological target in vascular smooth-muscle regulation. Curr Opin Investig Drugs 6, 920-933 (Pubitemid 41269372)
45. Woods NM, Cuthbertson KS, Cobbold PH (1986) Repetitive transient rises in cytoplasmic free calcium in hormonestimulated hepatocytes. Nature 319, 600-602 (Pubitemid 16110951)
46. 2+oscillations induced by hormonal stimulation of individual fura-2-loaded hepatocytes. J Biol Chem 264, 12859-12866 (Pubitemid 19194855)
47. Holl RW, Thorner MO, Mandell GL, Sullivan JA, Sinha YN, Leong DA (1988) Spontaneous oscillations of intracellular calcium and growth hormone secretion. J Biol Chem 263, 9682-9685
48. Sun MK, Alkon DL (2010) Pharmacology of protein kinase C activators: Cognition-enhancing and antidementic therapeutics. Pharmacol Ther 127, 66-77
49. 2+-ATPase in F344/BNF1 rats. Neurobiol Aging 19, 487-495 (Pubitemid 29065498)
50. Baudry M, DuBrin R, Beasley L, Leon M, Lynch G (1986) Low levels of calpain activity in Chiroptera brain: Implications for mechanisms of aging. Neurobiol Aging 7, 255-258 (Pubitemid 17172366)
51. Guttmann RP, Johnson GV (1998) Oxidative stress inhibits calpain activity in situ. J Biol Chem 273, 13331-13338 (Pubitemid 28246908)
52. Kayyali US, ZhangW, Yee AG, Seidman JG, Potter H (1997) Cytoskeletal changes in the brains of mice lacking calcineurin A alpha. J Neurochem 68, 1668-1678 (Pubitemid 27133077)
53. Lu T, Pan Y, Kao SY, Li C, Kohane I, Chan J, Yankner BA (2004) Gene regulation andDNAdamage in the ageing human brain. Nature 429, 883-891 (Pubitemid 38843301)
54. Saito K, Elce JS, Hamos JE, Nixon RA (1993) Widespread activation of calcium-activated neutral proteinase (calpain) in the brain in Alzheimer disease: A potential molecular basis for neuronal degeneration. Proc Natl Acad SciUS A 90, 2628-2632 (Pubitemid 23113469)
55. Lee JM, Zipfel GJ, Choi DW(1999) The changing landscape of ischaemic brain injury mechanisms. Nature 399, A7-A14 (Pubitemid 29295654)
56. Mattson MP, Rydel RE, Lieberburg I, Smith-Swintosky VL (1993) Altered Calcium signaling and neuronal injury: Stroke and Alzheimers disease as examples. Ann NY Acad Sci 679, 1-21 (Pubitemid 23202395)
57. Peterson C, Gibson G, Blass J (1985) Altered calcium uptake in cultured skin fibroblasts from patients with Alzheimers disease. N Engl J Med 312, 1063-1065 (Pubitemid 15114304)
58. Shelanski ML (1989) Intracellular ionic calcium and the cytoskeleton in living cells. Ann N Y Acad Sci 568, 121-124 (Pubitemid 20166526)
59. Nixon RA (1989) Calcium-activated neutral proteinases as regulators of cellular function. Implication for Alzheimers disease pathogenesis. Ann N Y Acad Sci 568, 198-208 (Pubitemid 20166537)
60. 2+ leak channels, a function disrupted by familial Alzheimers disease-linked mutations. Cell 126, 981-993 (Pubitemid 44310781)
61. Llińas R, Steinber IZ,Walton K (1981) Relationship between presynaptic caclium current and postsynaptic potentials in squid giant synapse. Biophys J 33, 323-351 (Pubitemid 11191467)
62. Jacoby S (2011) Never say die: The myth and marketing of the new old age, Pantheon Books, New York
63. Gillick MR (1998) Tangled minds: understanding Alzheimers disease and other dementia. Penquin Group, New York
64. Khachaturian ZS (2007) A chapter in the development of Alzheimers disease research: A case study of public policies on the development and funding of research programs. Alzheimers Dement 3, 243-258 (Pubitemid 46825510)
65. Allen M (2009) Aiming to revolutionize dementia research, An interview with the president of the Lou Ruvo Brain Institute. Las Vegas Sun Jan. 7, 2009